Wockhardt Limited (WOCKPHARMA) - Total Liabilities
Based on the latest financial reports, Wockhardt Limited (WOCKPHARMA) has total liabilities worth Rs-46.57 Billion INR (≈ $-503.64 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore WOCKPHARMA net assets growth trend to track the company's year-over-year net asset growth rate.
Wockhardt Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how Wockhardt Limited's total liabilities have evolved over time, based on quarterly financial data. See WOCKPHARMA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Wockhardt Limited Competitors by Total Liabilities
The table below lists competitors of Wockhardt Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CRISIL Limited
NSE:CRISIL
|
India | Rs14.14 Billion |
|
Schibsted ASA A
OL:SCHA
|
Norway | Nkr7.39 Billion |
|
Legend Biotech Corp
NASDAQ:LEGN
|
USA | $629.02 Million |
|
KPJ Healthcare Bhd
KLSE:5878
|
Malaysia | RM5.04 Billion |
|
Kirloskar Oil Engines Limited
NSE:KIRLOSENG
|
India | Rs72.77 Billion |
|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
USA | $219.59 Million |
|
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB
|
India | Rs6.05 Billion |
|
Nelnet Inc
NYSE:NNI
|
USA | $10.57 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down Wockhardt Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Wockhardt Limited.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Wockhardt Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Wockhardt Limited (2005–2025)
The table below shows the annual total liabilities of Wockhardt Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs34.78 Billion ≈ $376.13 Million |
-12.77% |
| 2024-03-31 | Rs39.87 Billion ≈ $431.18 Million |
-0.85% |
| 2023-03-31 | Rs40.21 Billion ≈ $434.86 Million |
-0.49% |
| 2022-03-31 | Rs40.41 Billion ≈ $437.02 Million |
+0.71% |
| 2021-03-31 | Rs40.12 Billion ≈ $433.93 Million |
-21.65% |
| 2020-03-31 | Rs51.21 Billion ≈ $553.87 Million |
+6.11% |
| 2019-03-31 | Rs48.26 Billion ≈ $521.96 Million |
-2.77% |
| 2018-03-31 | Rs49.64 Billion ≈ $536.86 Million |
-5.45% |
| 2017-03-31 | Rs52.50 Billion ≈ $567.77 Million |
+45.46% |
| 2016-03-31 | Rs36.09 Billion ≈ $390.34 Million |
+17.20% |
| 2015-03-31 | Rs30.80 Billion ≈ $333.04 Million |
+6.03% |
| 2014-03-31 | Rs29.04 Billion ≈ $314.10 Million |
-12.93% |
| 2013-03-31 | Rs33.36 Billion ≈ $360.76 Million |
-30.25% |
| 2012-03-31 | Rs47.83 Billion ≈ $517.24 Million |
+0.43% |
| 2011-03-31 | Rs47.62 Billion ≈ $515.01 Million |
-2.62% |
| 2010-03-31 | Rs48.90 Billion ≈ $528.88 Million |
-14.36% |
| 2009-03-31 | Rs57.10 Billion ≈ $617.55 Million |
+47.19% |
| 2008-03-31 | Rs38.80 Billion ≈ $419.56 Million |
+46.51% |
| 2007-03-31 | Rs26.48 Billion ≈ $286.36 Million |
+98.67% |
| 2006-03-31 | Rs13.33 Billion ≈ $144.14 Million |
+2.35% |
| 2005-03-31 | Rs13.02 Billion ≈ $140.83 Million |
-- |
About Wockhardt Limited
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH… Read more